Literature DB >> 25496103

An official American Thoracic Society Clinical Practice guideline: the diagnosis of intensive care unit-acquired weakness in adults.

Eddy Fan, Fern Cheek, Linda Chlan, Rik Gosselink, Nicholas Hart, Margaret S Herridge, Ramona O Hopkins, Catherine L Hough, John P Kress, Nicola Latronico, Marc Moss, Dale M Needham, Mark M Rich, Robert D Stevens, Kevin C Wilson, Chris Winkelman, Doug W Zochodne, Naeem A Ali.   

Abstract

RATIONALE: Profound muscle weakness during and after critical illness is termed intensive care unit-acquired weakness (ICUAW).
OBJECTIVES: To develop diagnostic recommendations for ICUAW.
METHODS: A multidisciplinary expert committee generated diagnostic questions. A systematic review was performed, and recommendations were developed using the Grading, Recommendations, Assessment, Development, and Evaluation (GRADE) approach. MEASUREMENT AND MAIN
RESULTS: Severe sepsis, difficult ventilator liberation, and prolonged mechanical ventilation are associated with ICUAW. Physical rehabilitation improves outcomes in heterogeneous populations of ICU patients. Because it may not be feasible to provide universal physical rehabilitation, an alternative approach is to identify patients most likely to benefit. Patients with ICUAW may be such a group. Our review identified only one case series of patients with ICUAW who received physical therapy. When compared with a case series of patients with ICUAW who did not receive structured physical therapy, evidence suggested those who receive physical rehabilitation were more frequently discharged home rather than to a rehabilitative facility, although confidence intervals included no difference. Other interventions show promise, but fewer data proving patient benefit existed, thus precluding specific comment. Additionally, prior comorbidity was insufficiently defined to determine its influence on outcome, treatment response, or patient preferences for diagnostic efforts. We recommend controlled clinical trials in patients with ICUAW that compare physical rehabilitation with usual care and further research in understanding risk and patient preferences.
CONCLUSIONS: Research that identifies treatments that benefit patients with ICUAW is necessary to determine whether the benefits of diagnostic testing for ICUAW outweigh its burdens.

Entities:  

Keywords:  critical care; critical illness myoneuropathy; critical illness myopathy; critical illness polyneuropathy; definitions; diagnosis; intensive care unit–acquired weakness

Mesh:

Year:  2014        PMID: 25496103     DOI: 10.1164/rccm.201411-2011ST

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  109 in total

1.  Finally, a time and place for electrophysiological testing in critically ill patients?

Authors:  Eddy Fan; Margaret S Herridge
Journal:  Intensive Care Med       Date:  2015-09-30       Impact factor: 17.440

2.  Electromyography and nerve conduction studies in critical care: step by step in the right direction.

Authors:  Neha S Dangayach; Martin Smith; Jan Claassen
Journal:  Intensive Care Med       Date:  2015-11-17       Impact factor: 17.440

3.  Impact of Vasoactive Medications on ICU-Acquired Weakness in Mechanically Ventilated Patients.

Authors:  Krysta S Wolfe; Bhakti K Patel; Erica L MacKenzie; Shewit P Giovanni; Anne S Pohlman; Matthew M Churpek; Jesse B Hall; John P Kress
Journal:  Chest       Date:  2018-09-11       Impact factor: 9.410

Review 4.  Assessment of impairment and activity limitations in the critically ill: a systematic review of measurement instruments and their clinimetric properties.

Authors:  Selina M Parry; Catherine L Granger; Sue Berney; Jennifer Jones; Lisa Beach; Doa El-Ansary; René Koopman; Linda Denehy
Journal:  Intensive Care Med       Date:  2015-02-05       Impact factor: 17.440

5.  Assessment of quadriceps muscle mass with ultrasound in critically ill patients: intra- and inter-observer agreement and sensitivity.

Authors:  Johan Segers; Greet Hermans; Noppawan Charususin; Tom Fivez; Ilse Vanhorebeek; Greet Van den Berghe; Rik Gosselink
Journal:  Intensive Care Med       Date:  2015-01-29       Impact factor: 17.440

6.  Unraveling the myriad contributors to persistent diminished exercise capacity after critical illness.

Authors:  Nicola Latronico; Margaret S Herridge
Journal:  Intensive Care Med       Date:  2015-07-10       Impact factor: 17.440

7.  Malignant Pleural Effusion Management.

Authors:  Lucía Ferreiro; Juan Suárez-Antelo; Luis Valdés
Journal:  Arch Bronconeumol (Engl Ed)       Date:  2020-07-02       Impact factor: 4.872

8.  ICU Admission Muscle and Fat Mass, Survival, and Disability at Discharge: A Prospective Cohort Study.

Authors:  Ariel Jaitovich; Malik M H S Khan; Ria Itty; Hau C Chieng; Camille L Dumas; Pallavi Nadendla; John P Fantauzzi; Recai M Yucel; Paul J Feustel; Marc A Judson
Journal:  Chest       Date:  2018-10-28       Impact factor: 9.410

9.  Diaphragmatic dysfunction in patients with ICU-acquired weakness and its impact on extubation failure.

Authors:  Boris Jung; Pierre Henri Moury; Martin Mahul; Audrey de Jong; Fabrice Galia; Albert Prades; Pierre Albaladejo; Gerald Chanques; Nicolas Molinari; Samir Jaber
Journal:  Intensive Care Med       Date:  2015-11-16       Impact factor: 17.440

10.  Can Sarcopenia Quantified by Ultrasound of the Rectus Femoris Muscle Predict Adverse Outcome of Surgical Intensive Care Unit Patients as well as Frailty? A Prospective, Observational Cohort Study.

Authors:  Noomi Mueller; Sushila Murthy; Christopher R Tainter; Jarone Lee; Kathleen Riddell; Florian J Fintelmann; Stephanie D Grabitz; Fanny P Timm; Benjamin Levi; Tobias Kurth; Matthias Eikermann
Journal:  Ann Surg       Date:  2016-12       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.